ClassID:

94106

C07D209/30 - CPC Classification

Classification description:

Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring; Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring

Sub-classes:
Recent Application in this class:
#1
20260138948
2026-05-21

N-SUBSTITUTED INDOLES AS 5-HYDROXYTRYPTAMINE (5-HT) SEROTONIN RECEPTOR AGONISTS AND ANTAGONISTS

#2
20260109670
2026-04-23

METHOD FOR ARYL DEBROMINATION AND ACYLATION OF BROMINATED BENZO-FUSED NITROGEN HETEROCYCLE

#3
20260078090
2026-03-19

N-SUBSTITUTED INDOLES AS 5-HYDROXYTRYPTAMINE (5-HT) SEROTONIN RECEPTOR AGONISTS AND ANTAGONISTS

#4
20250382269
2025-12-18

METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES

#5
20250382268
2025-12-18

METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES

#6
20250333411
2025-10-30

COMPOUNDS AND METHODS FOR INHIBITING FASCIN

#7
20250325516
2025-10-23

SEROTONIN ANALOGUES FOR USE IN TREATING METALLOPTOSIS-ASSOCIATED DISORDERS

#8
20250042853
2025-02-06

BICYCLIC COMPOUND AND APPLICATION THEREOF

#9
20250011284
2025-01-09

Crystalline forms of (E)-N-hydroxy-3-(1-(phenylsulfonyl)indolin-5-yl)acrylamide

#10
20250011283
2025-01-09

CRYSTALLINE FORMS OF (E)-N-HYDROXY-3-(1-(PHENYLSULFONYL)INDOLIN-5-YL)ACRYLAMIDE

#11
20240425486
2024-12-26

FUSED BICYCLIC SUBSTITUTED N-(1H-INDOL-7-YL)BENZENESULFONAMIDES AND USES THEREOF

#12
20240408093
2024-12-12

HETEROBIFUNCTIONAL COMPOUNDS AND THEIR USE IN TREATING DISEASE

#13
20240327351
2024-10-03

AMIDE AND ETHER SUBSTITUTED N-(1H-INDOL-7-YL)BENZENESULFONAMIDES AND USES THEREOF

#14
20240308986
2024-09-19

ESTROGEN RECEPTOR-MODULATING COMPOUNDS

#15
20240124449
2024-04-18

Compounds and methods for inhibiting fascin

#16
20240124400
2024-04-18

LPXH TARGETING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF MAKING AND USING THE SAME

#17
20240043423
2024-02-08

COMPOUNDS AND METHODS FOR TREATMENT OF HEDGEHOG PATHWAY ASSOCIATED CONDITIONS

#18
20230398097
2023-12-14

CARBOXYLATED PSILOCYBIN DERIVATIVES AND METHODS OF USING

#19
20230391714
2023-12-07

INHIBITORS OF THE INTERACTION BETWEEN TRIP8B AND HCN CHANNELS AND USES THEREOF FOR TREATING NEUROLOGICAL DISEASES AND DISORDERS

#20
20230348384
2023-11-02

Aza (Indole)-, Benzothiophene-, And Benzofuran-3-Sulfonamides

#21
20230285598
2023-09-14

SULFOXONIUM YLIDE DERIVATIVES AS PROBES FOR CYSTEINE PROTEASE

#22
20230227406
2023-07-20

MODULATORS OF E3 LIGASES

#23
20230219890
2023-07-13

BICYCLIC COMPOUNDS AND USE THEREOF

#24
20230218578
2023-07-13

BENZOPYRAZOLE COMPOUNDS AND ANALOGUES THEREOF

#25
20230174481
2023-06-08

KINASE INHIBITORS

#26
20230174470
2023-06-08

COMPOUND AS A UBR BOX DOMAIN LIGAND

#27
20230174465
2023-06-08

COMPOUND AS A UBR BOX DOMAIN LIGAND

#28
20230159502
2023-05-25

INDOLE DERIVATIVES AS ALPHA-1-ANTITRYPSIN MODULATORS FOR TREATING ALPHA-1-ANTITRYPSIN DEFICIENCY (AATD)

#29
20230159456
2023-05-25

N-SUBSTITUTED INDOLES

#30
20230063230
2023-03-02

NURR1 RECEPTOR MODULATORS

#31
20230044066
2023-02-09

Carboxylated psilocybin derivatives and methods of using

#32
20220377951
2022-11-24

Shielding cover and display device

#33
20220332704
2022-10-20

Estrogen receptor-modulating compounds

#34
20220298112
2022-09-22

N-(PHENYL)-Indole-3-Sulfonamide Derivatives And Related Compounds As GPR17 Modulators For Treating CNS Disorders Such As Multiple Sclerosis

#35
20220127227
2022-04-28

Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides

#36
20220048858
2022-02-17

Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides

#37
20220017463
2022-01-20

Salt form of estrogen receptor downregulator, crystalline form thereof, and preparation method therefor

#38
20210347773
2021-11-11

Activator of TREK (TWIK RElated Kchannels) channels

#39
20210340138
2021-11-04

Compounds and methods for inhibiting fascin

#40
20210284606
2021-09-16

TETRALIN AND INDANE DERIVATIVES AND USES THEREOF

#41
20210260035
2021-08-26

Indole compounds and analogues thereof

#42
20210214353
2021-07-15

Compounds and methods for treatment of hedgehog pathway associated conditions

#43
20210024464
2021-01-28

BINDING FUNCTION 3 (BF3) SITE COMPOUNDS AS THERAPEUTICS AND METHODS FOR THEIR USE

#44
20200399218
2020-12-24

Antimicrobial compounds, compositions, and articles of manufacture for selectively inhibiting pathogenic microbes

#45
20200399217
2020-12-24

Methods and compositions for selectively inhibiting pathogenic microbes

#46
20200347032
2020-11-05

Estrogen receptor-modulating compounds

#47
20200247749
2020-08-06

Keratin dyeing compounds, compositions containing them, and method and use thereof

#48
20200207726
2020-07-02

INDOLINYL SULFONAMIDE AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORY AND THE TREATMENT OF DISEASE

#49
20200157050
2020-05-21

KCNQ2-5 CHANNEL ACTIVATOR

#50
20200115333
2020-04-16

TETRALIN AND INDANE DERIVATIVES AND USES THEREOF

#51
20200062790
2020-02-27

Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders

#52
20200039976
2020-02-06

Compounds and methods for inhibiting fascin

#53
20200039933
2020-02-06

Nrf and HIF activators/HDAC inhibitors and therapeutic methods using the same

#54
20190345104
2019-11-14

Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides

#55
20190337893
2019-11-07

ANTIBIOTIC SENSITIVITY-RESTORING AND PHOTOSENSITIVE AGENTS

#56
20190322662
2019-10-24

Activator of TREK (TWIK RElated K channels) channels

#57
20190300480
2019-10-03

Binding Function 3 (BF3) site compounds as therapeutics and methods for their use

#58
20190241588
2019-08-08

Tricyclic sulfones as RORγ modulators

#59
20190241517
2019-08-08

Method for the preparation of H-Arg(MIS)-OH

#60
20190210973
2019-07-11

COMPOUNDS AND METHODS FOR TREATMENT OF CYSTIC FIBROSIS

#61
20190185498
2019-06-20

Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders

#62
20190144473
2019-05-16

Amino compounds for treatment of complement mediated disorders

#63
20190085005
2019-03-21

Phosphonate compounds for treatment of complement mediated disorders

#64
20190048033
2019-02-14

Ether compounds for treatment of complement mediated disorders

#65
20190031692
2019-01-31

Compounds for treatment of complement mediated disorders

#66
20190023729
2019-01-24

Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders

#67
20180346422
2018-12-06

KCNQ2-5 channel activator

#68
20180319743
2018-11-08

TETRALIN AND INDANE DERIVATIVES AND USES THEREOF

#69
20180298043
2018-10-18

Alkyne Compounds for Treatment of Complement Mediated Disorders

#70
20180297948
2018-10-18

Sodium channel blockers

#71
20180291047
2018-10-11

ALKYNE COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS

#72
20180291046
2018-10-11

ALKYNE COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS

#73
20180258075
2018-09-13

Substituted 1H-indole-2-carboxamide compounds as indoleamine-2,3-dioxygenase inhibitors

#74
20180230102
2018-08-16

Carboxy substituted (hetero) aromatic ring derivatives and preparation method and uses thereof

#75
20180215757
2018-08-02

Compounds and methods for inhibiting fascin

#76
20180208564
2018-07-26

1,2-dithiolane and dithiol compounds useful in treating mutant EGFR-mediated diseases and conditions

#77
20180155286
2018-06-07

Antibiotic sensitivity-restoring and photosensitive agents

#78
20180086697
2018-03-29

Inhibitors of human immunodeficiency virus replication

#79
20180002358
2018-01-04

Tricyclic sulfones as RORγ modulators

#80
20170334855
2017-11-23

KCNQ2-5 channel activator

#81
20170298085
2017-10-19

Carbamate, ester, and ketone compounds for treatment of complement mediated disorders

#82
20170298084
2017-10-19

Amide compounds for treatment of complement mediated disorders

#83
20170247321
2017-08-31

TETRALIN AND INDANE DERIVATIVES AND USES THEREOF

#84
20170226142
2017-08-10

Factor D Inhibitors Useful for Treating Inflammatory Disorders

#85
20170189410
2017-07-06

Amino compounds for treatment of complement mediated disorders

#86
20170158692
2017-06-08

Compounds and methods for inhibiting fascin

#87
20170029372
2017-02-02

Binding function (BF) site compounds as therapeutics and methods for their use

#88
20160376260
2016-12-29

Slow release of organoboronic acids in cross-coupling reactions

#89
20160362417
2016-12-15

Process for the preparation of 5-fluorotryptophol

#90
20160326195
2016-11-10

Tricyclic sulfones as RORγ modulators

#91
20160304453
2016-10-20

Antibiotic sensitivity-restoring and photosensitive agents

#92
20160237035
2016-08-18

Use of substituted dihydrooxindolylsulfonamides, or the salts thereof, for increasing the stress tolerance of plants

#93
20160221946
2016-08-04

Sulfonylindole derivatives and method for preparing the same

#94
20160214935
2016-07-28

Autotaxin inhibitor compounds

#95
20160185721
2016-06-30

Indole-carboxamides

#96
20160130214
2016-05-12

1,3-diaminocyclopentane carboxamide derivatives

#97
20160083363
2016-03-24

Substituted indoles as selective protease activated receptor 4 (PAR-4) antagonists

#98
20160002224
2016-01-07

Indole derivatives useful as anti-diabetic agents

#99
20150376173
2015-12-31

Sphingosine-1-phosphate receptor agonists, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent

#100
20150344425
2015-12-03

Indole carboxamide derivatives as P2Xreceptor antagonists

#101
20150313898
2015-11-05

Compounds that inhibit human DNA ligases and methods of treating cancer

#102
20150306095
2015-10-29

Indolinone derivative as tyrosine kinase inhibitor

#103
20150299191
2015-10-22

Compounds and methods for inhibiting fascin

#104
20150291584
2015-10-15

GPR40 receptor agonist, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent

#105
20150266817
2015-09-24

Tetralin and indane derivatives and uses thereof

#106
20150263296
2015-09-17

Organic electroluminescent device

#107
20150217283
2015-08-06

Metal complexes, especially the ruthenium complexes, and use thereof

#108
20150203490
2015-07-23

Ring-fused compound

#109
20150183744
2015-07-02

Activators of human pyruvate kinase

#110
20150164861
2015-06-18

Autotaxin inhibitors and uses thereof

#111
20150099781
2015-04-09

Compounds and methods for treating mammalian gastrointestinal microbial infections

#112
20150065552
2015-03-05

Use of indolyl and indolinyl hydroxamates for treating heart failure of neuronal injury

#113
20140364477
2014-12-11

Indolyl or indolinyl hydroxamate compounds

#114
20140343114
2014-11-20

Potent poxvirus inhibitor

#115
20140249197
2014-09-04

Indole derivatives as selective androgen receptor modulators (SARMS)

#116
20140179932
2014-06-26

(aza)indole derivative and use thereof for medical purposes

#117
20140142082
2014-05-22

Pyrrolo sulfonamide compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-γ (ROR-γ, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune diseases

#118
20140113891
2014-04-24

Compounds that inhibit human DNA ligases and methods of treating cancer

#119
20140073656
2014-03-13

SERMs for the treatment of estrogen receptor-mediated disorders

#120
20140005386
2014-01-02

p53-Mdm2 antagonists

#121
20140005221
2014-01-02

Ring-fused compound

#122
20130303767
2013-11-14

Thionating agent

#123
20130274253
2013-10-17

Pyrimidine derivatives, preparation thereof, and pharmaceutical use thereof as akt(pkb) phosphorylation inhibitors

#124
20130259830
2013-10-03

CRTH2 MODULATORS

#125
20130252955
2013-09-26

(aza)indole derivative and use thereof for medical purposes

#126
20130184276
2013-07-18

Modulators of ATP-binding cassette transporters

#127
20130150326
2013-06-13

Autotaxin inhibitors and uses thereof

#128
20130102774
2013-04-25

Thionation process and a thionating agent

#129
20120263848
2012-10-18

Organic Compounds

#130
20120232070
2012-09-13

Use of Indole Derivatives as Nurr-1 Activators for the Application Thereof as a Medicament for the Treatment of Parkinson's Disease

#131
20120178764
2012-07-12

Novel Compounds

#132
20120101096
2012-04-26

Compounds and methods for treating mammalian gastrointestinal microbial infections

#133
20120088837
2012-04-12

Tetralin and indane derivatives and uses thereof

#134
20120004315
2012-01-05

Selective estrogen receptor modulator

#135
20110281849
2011-11-17

Aryl indolyl sulfonamide compounds and their use as 5-HTligands

#136
20110268698
2011-11-03

METHODS FOR TREATING HEPATITIS C

#137
20110263614
2011-10-27

Novel compounds

#138
20110245315
2011-10-06

Indolyl or indolinyl hydroxamate compounds

#139
20110230454
2011-09-22

(aza)indole derivative and use thereof for medical purposes

#140
20110104074
2011-05-05

METHODS FOR TARGETED CANCER TREATMENT AND DETECTION

#141
20110065768
2011-03-17

Non-steroidal androgens compounds

#142
20110060125
2011-03-10

Indolesulfonyl protecting groups for protection of guanidino and amino groups

#143
20110046394
2011-02-24

Pharmaceutical process and intermediates 714

#144
20110033393
2011-02-10

Hydrazone Compounds and Their Use

#145
20110015401
2011-01-20

Metal-Catalyzed Carbon-Fluorine Bond Formation

#146
20110009428
2011-01-13

NOVEL ANDROGENS

#147
20110003851
2011-01-06

Small molecule hematopoietic growth factor mimetic compounds that activate hematopoietic growth factor receptors

#148
20100311797
2010-12-09

Novel Compounds

#149
20100305100
2010-12-02

METHODS FOR TREATING HEPATITIS C

#150
20100292187
2010-11-18

Methods for treating hepatitis C

#151
20100286137
2010-11-11

Method of treating conditions involving PPAR-receptors with indole compounds

#152
20100280092
2010-11-04

N-acylhydrazone derivatives useful as modulators of nicotinic acetylcholine receptors

#153
20100267754
2010-10-21

INTEGRIN EXPRESSION INHIBITOR

#154
20100240644
2010-09-23

Morpholine derivative

#155
20100197937
2010-08-05

Compound, probe containing the novel compound, and fluorescence-imaging contrast agent containing the novel compound or the probe

#156
20100197756
2010-08-05

Indole-3-Sulphur Derivatives

#157
20100197687
2010-08-05

Indoles Useful in the Treatment of Inflammation

#158
20100197657
2010-08-05

2-ARYL OR HETEROARYL INDOLE DERIVATIVES

#159
20100190761
2010-07-29

DIPHENYL SUBSTITUTED ALKANES

#160
20100168098
2010-07-01

Viral polymerase inhibitors

#161
20100144823
2010-06-10

Indole derivatives as selective androgen receptor modulators (SARMS)

#162
20100137616
2010-06-03

Indole compounds useful as serotonin selective agents

#163
20100121062
2010-05-13

Slow release of organoboronic acids in cross-coupling reactions

#164
20100120885
2010-05-13

Derivatives of psammaplin A, a method for their synthesis and their uses for the prevention or treatment of cancer

#165
20100108995
2010-05-06

Organic electroluminescent device

#166
20100099683
2010-04-22

Compounds that inhibit human DNA ligases and methods of treating cancer

#167
20100087484
2010-04-08

Aminoalkoxy aryl sulfonamide compounds and their use as 5-HTligands

#168
20100087446
2010-04-08

2-SUBSTITUTED INDOLE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS

#169
20100056521
2010-03-04

(Aza)indole derivative and use thereof for medical purposes

#170
20100048590
2010-02-25

N-(3-AMINO-2-HYDROXY-PROPYL) SUBSTITUTED ALKYLAMIDE COMPOUNDS

#171
20100041669
2010-02-18

4-(HETEROCYCLYL)ALKYL-N-(ARYLSULFONYL)INDOLE COMPOUNDS AND THEIR USE AS 5-HT6 LIGANDS

#172
20100016312
2010-01-21

Substituted indolyl and indazolyl derivatives and uses thereof

#173
20100016308
2010-01-21

Tetrahydroindole derivatives for treatment of alzheimer's disease

#174
20090326036
2009-12-31

[2-(6-fluoro-1H-indol-3-ylsulfanyl)benzyl]methyl amine for the treatment of affective disorders

#175
20090325930
2009-12-31

Selective estrogen receptor modulator

#176
20090291948
2009-11-26

SULFONAMIDE PERI-SUBSTITUTED BICYCLICS FOR OCCLUSIVE ARTERY DISEASE

#177
20090264653
2009-10-22

Useful indole compounds

#178
20090253756
2009-10-08

Indole amide derivatives as EP4 receptor antagonists

#179
20090247573
2009-10-01

(Hetero)aryl cyclohexane derivatives

#180
20090216023
2009-08-27

Indole derivatives as selective androgen receptor modulators (SARMS)

#181
20090176764
2009-07-09

2-PHENYL-1-[4-(2-AMINOETHOXY)-BENZYL]-INDOLES AS ESTROGENIC AGENTS

#182
20090163518
2009-06-25

Novel Compounds

#183
20090143449
2009-06-04

Bi-aryl or aryl-heteroaryl substituted indoles

#184
20090118323
2009-05-07

ANTITUMOR BENZOYLSULFONAMIDES

#185
20090099236
2009-04-16

3-amino-1-arylpropyl indoles and AZA-substituted indoles and uses thereof

#186
20090099164
2009-04-16

Phenylaminopropanol Derivatives and Methods of Their Use

#187
20090093469
2009-04-09

Phenylaminopropanol Derivatives and Methods of Their Use

#188
20090087409
2009-04-02

Viral polymerase inhibitors

#189
20090054511
2009-02-26

Tryptophan derivative and application thereof

#190
20090047246
2009-02-19

NOVEL INHIBITORS OF HEPATITIS C VIRUS REPLICATION

#191
20090023796
2009-01-22

Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents

#192
20080293751
2008-11-27

Tetralin and indane derivatives and uses thereof

#193
20080293745
2008-11-27

New amino-alkyl-amide derivatives as CCR3 receptor ligands

#194
20080249110
2008-10-09

Substituted 3-sulfur indoles

#195
20080214645
2008-09-04

Uses of 2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRIS

#196
20080214644
2008-09-04

2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRIs

#197
20080188532
2008-08-07

Indole compound and use thereof

#198
20080176922
2008-07-24

Uses of 2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRIS

#199
20080153816
2008-06-26

Indole compounds, method of preparing them and uses thereof

#200
20080146587
2008-06-19

Indole and benzofuran 2-carboxamide derivatives and uses thereof

#201
20080096903
2008-04-24

SULFAMOYL-CONTAINING DERIVATIVES AND USES THEREOF

#202
20080051586
2008-02-28

Process for the preparation of substituted indoles

#203
20080027074
2008-01-31

2-(1H-indolylsulfanyl)-aryl amine derivatives for use in the treatment of affective disorders, pain, ADHD and stress urinary incontinence

#204
20080021017
2008-01-24

2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents

#205
20070299266
2007-12-27

Crystal of two-ring heterocyclic sulfonamide compound

#206
20070299069
2007-12-27

Methods for treating hepatitis C

#207
20070299068
2007-12-27

Methods for treating hepatitis C

#208
20070287712
2007-12-13

Piperazine enamines as antiviral agents

#209
20070275965
2007-11-29

Bicyclic, nitrogen-containing compounds modulating CXCR4 and/or CCXCKR2

#210
20070238775
2007-10-11

Modulators of ATP-binding cassette transporters

#211
20070232682
2007-10-04

Indole compounds having sphingosine-1-phosphate (S1P) receptor antagonist

#212
20070232681
2007-10-04

Compounds Having Crth2 Antagonist Activity

#213
20070225352
2007-09-27

Androgens

#214
20070225285
2007-09-27

5-LIPOXYGENASE-ACTIVATING PROTEIN (FLAP) INHIBITORS

#215
20070208004
2007-09-06

Indol-1-yl-acetic acid derivatives

#216
20070203120
2007-08-30

Sulfonyl substituted 1H-indoles as ligands for the 5-hydroxytryptamine receptors

#217
20070203099
2007-08-30

Anionically substituted 7-nitroindoline derivatives and their uses

#218
20070197629
2007-08-23

Indole derivative and application thereof

#219
20070167498
2007-07-19

Carboxylic acid compounds

#220
20070161689
2007-07-12

Indoles having anti-diabetic activity

#221
20070155790
2007-07-05

Meta-benzamidine derivatives as serine protease inhibitors

#222
20070142453
2007-06-21

1-Alkyl-3-thio-substituted indole-2-alkynoic acids useful for the treatment of alzheimer's disease and related conditions

#223
20070142380
2007-06-21

Viral polymerase inhibitors

#224
20070135511
2007-06-14

Indole derivatives useful as progesterone receptor modulators

#225
20070123527
2007-05-31

3-amino-1-arylpropyl indoles and aza-substituted indoles and uses thereof

#226
20070099916
2007-05-03

Indolyl derivatives as liver-X-receptor (LXR) modulators

#227
20070082907
2007-04-12

Peroxisome proliferator activated receptor modulators

#228
20070054895
2007-03-08

2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents

#229
20070049591
2007-03-01

Inhibitors of MAPK/Erk Kinase

#230
20060293306
2006-12-28

Viral polymerase inhibitors

#231
20060287382
2006-12-21

2-(1H-indolylsulfanyl)-aryl amine derivatives

#232
20060229296
2006-10-12

2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents

#233
20060194817
2006-08-31

N- (3-amino-2-hydroxy-propyl) substituted alkylamide compounds

#234
20060178420
2006-08-10

Indole derivatives as anti-inflammatory agents

#235
20060167255
2006-07-27

Tetralin and indane derivatives and uses thereof

#236
20060160880
2006-07-20

2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRI

#237
20060160798
2006-07-20

Viral polymerase inhibitors

#238
20060148815
2006-07-06

4-phenyl-1-piperazinyl, -piperidinyl and -tetrahydropyridyl derivatives

#239
20060135540
2006-06-22

PPAR active compounds

#240
20060128785
2006-06-15

Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents

#241
20060128722
2006-06-15

Indoles useful in the treatment of androgen-receptor related diseases

#242
20060116416
2006-06-01

PPAR active compounds

#243
20060116364
2006-06-01

Selective estrogen receptor modulator

#244
20060111427
2006-05-25

Indole derivatives useful as progesterone receptor modulators

#245
20060111426
2006-05-25

Indole-3-sulphur derivatives

#246
20060106053
2006-05-18

Antitumor benzoylsulfonamides

#247
20060100266
2006-05-11

Indole compounds useful as serotonin selective agents

#248
20060094711
2006-05-04

2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents

#249
20060079520
2006-04-13

Sulfonamide peri-substituted bicyclics for occlusive artery disease

#250
20060052606
2006-03-09

Factor Xa inhibitors

#251
20060030613
2006-02-09

Indole, indazole and indoline derivatives as CETP inhibitors

#252
20060020003
2006-01-26

Biphenyloxy-acids

#253
20050277685
2005-12-15

Indoles having anti-diabetic activity

#254
20050267194
2005-12-01

Indole compounds

#255
20050267108
2005-12-01

Indole compounds

#256
20050256316
2005-11-17

Preparation of phosphatase inhibitors

#257
20050250741
2005-11-10

Indole derivatives as selective androgen receptor modulators (SARMS)

#258
20050245515
2005-11-03

Indolyl derivatives as liver-X-receptor (LXR) modulators

#259
20050234242
2005-10-20

Process for cross coupling indoles

#260
20050222148
2005-10-06

Phenylaminopropanol derivatives and methods of their use

#261
20050215616
2005-09-29

2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents

#262
20050215587
2005-09-29

Serine protease inhibitors

#263
20050176803
2005-08-11

Indole derivatives as anti-inflammatory agents

#264
20050176712
2005-08-11

Integrin expression inhibitor

#265
20050171186
2005-08-04

Thio-oxindole derivatives

#266
20050171118
2005-08-04

New indole derivatives with 5-HT6 receptor affinity

#267
20050165055
2005-07-28

Substituted indoles

#268
20050054711
2005-03-10

Thio-oxindole derivatives

#269
20050032790
2005-02-10

Compounds

#270
20050026905
2005-02-03

2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents

#271
20050004167
2005-01-06

Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases